SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Choice Institutional Equities Recommends Buying Senores Pharma, Sets Rs 1,700 Target

Choice Institutional Equities expects stronger H2FY27, citing product launches and revenue contributions from Zoraya and Amerisyn. It projects revenue CAGR of about 30% over the next three years, in line with management guidance.

SquawkNews Desk

Related stories

AMD, Nvidia, Micron and Arm shares fall AMD fell 6.5%, Nvidia 2.5%, Micron 3.7% and Arm 7.5%. M impact | EQUITY | Oct 30, 2026, 08:59 AM UTC BlackRock Raises Combined Stake in Tryg Above 5% BlackRock's combined holding in Tryg has risen above 5%. M impact | EQUITY | Oct 30, 2026, 08:59 AM UTC Jiangxi Copper falls more than 6% again intraday M impact | EQUITY | Oct 30, 2026, 08:57 AM UTC Court Accepts Bankruptcy Liquidation Application Against CNG Weihai A court accepted a bankruptcy liquidation application against CNG Weihai on Oct. 29, 2026. M impact | EQUITY | Oct 30, 2026, 08:56 AM UTC FOKUS 3-BP Reports Record Third-Quarter Profit M impact | EQUITY | Oct 30, 2026, 08:51 AM UTC BP reports record $8.46 billion third-quarter profit, beats forecasts M impact | EQUITY | Oct 30, 2026, 08:49 AM UTC